Mr Beck joins Ardea Biosciences from Metabasis Therapeutics, which he co-founded in 1999 and where he served most recently as senior vice president of finance, CFO and treasurer.
Barry Quart, president and CEO of Ardea Biosciences, said: “John has served as a member of our board of directors since June 2007. He is a proven leader with more than 20 years of financial management experience. We believe that he will play an important role in our ongoing success.”